Today: 11 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Vera Therapeutics (VERA) Stock Dips in Thin Post‑Christmas Trading as Wall Street Weighs FDA Filing, $300M Raise, and IgA Nephropathy Competition

Vera Therapeutics (VERA) Stock Dips in Thin Post‑Christmas Trading as Wall Street Weighs FDA Filing, $300M Raise, and IgA Nephropathy Competition

Vera Therapeutics shares fell 2.6% to $54.24 midday Friday in thin post-holiday trading, with no major news driving the move. The stock has recently digested a Biologics License Application filing for atacicept in IgA nephropathy, a resolved public offering, and increased competition in the IgAN market. Trading volume remained light, typical for the year-end period.
26 December 2025
Concentrix Corporation Stock (CNXC) Trades Near $42 as Wall Street Reopens Post-Christmas: AI Push, Earnings Date, Analyst Targets

Concentrix Corporation Stock (CNXC) Trades Near $42 as Wall Street Reopens Post-Christmas: AI Push, Earnings Date, Analyst Targets

Concentrix (CNXC) traded nearly flat Friday morning, last quoted at $41.67, down 0.05% with early volume above 85,000 shares. The company will report Q4 and full-year 2025 results before market open on Jan. 13, 2026. Major U.S. equity ETFs were slightly higher, while small caps and bond ETFs showed mixed moves. Concentrix recently launched pre-built conversational AI agents targeting enterprise clients.
26 December 2025
··
Micron (MU) Stock Today: AI Memory Demand, Record Guidance, and Fresh Wall Street Targets Drive a Volatile Post‑Christmas Session

Micron (MU) Stock Today: AI Memory Demand, Record Guidance, and Fresh Wall Street Targets Drive a Volatile Post‑Christmas Session

Micron Technology shares traded at $285.37, down 0.46% at 10:42 a.m. ET Friday in light post-Christmas trading. The move follows a record fiscal Q1 report and strong Q2 guidance, with projected revenue of $18.7 billion and non-GAAP EPS of $8.42, both well above analyst estimates. Micron stock has surged about 240% in 2025, driven by AI-related demand and tight memory supply.
26 December 2025
·
Nike Stock (NYSE: NKE) Trades Higher in Holiday Week as Tim Cook Buys Shares; Tariffs and China “Reset” Dominate the 2026 Outlook

Nike Stock (NYSE: NKE) Trades Higher in Holiday Week as Tim Cook Buys Shares; Tariffs and China “Reset” Dominate the 2026 Outlook

Nike shares rose about 1.2% to $60.73 in early Friday trading after Apple CEO Tim Cook bought $3 million in Nike stock, nearly doubling his stake. The purchase follows a sharp drop after Nike’s December 18 earnings, with volume light in the post-holiday market. Cook’s buy was the largest by a Nike director or executive in over a decade, according to Baird.
26 December 2025
·
Wave Life Sciences (WVE) Stock Today: Obesity Drug Catalyst, $402.5M Financing, and What Investors Are Watching Next

Wave Life Sciences (WVE) Stock Today: Obesity Drug Catalyst, $402.5M Financing, and What Investors Are Watching Next

Wave Life Sciences shares fell 0.74% to $18.12 late Thursday morning, underperforming the broader market as biotech stocks slipped. Earlier this month, Wave reported positive Phase 1 data for its obesity drug candidate WVE-007 and raised $402.5 million in an upsized equity offering, extending its cash runway into Q3 2028.
26 December 2025
··
Sunrun Stock (NASDAQ: RUN) News Today: NRG Texas Virtual Power Plant Deal, Tax-Credit Deadline, and Analyst Targets as Markets Rally

Sunrun Stock (NASDAQ: RUN) News Today: NRG Texas Virtual Power Plant Deal, Tax-Credit Deadline, and Analyst Targets as Markets Rally

Sunrun shares traded near $19.78 Friday morning after opening at $20.10, with early volume around 428,000. The company recently announced a Texas partnership with NRG’s Reliant to expand grid services using home batteries. Investors are watching the impact of a looming tax-credit cliff and shifting Federal Reserve rate policy on Sunrun’s financing costs. The S&P 500 hovered near record highs in thin post-holiday trading.
26 December 2025
··
2026 Tax Refund Season Could Bring Bigger Checks: IRS Withholding Decision, “Free Money” Buzz, and Key Filing Changes Under the One Big Beautiful Bill Act

2026 Tax Refund Season Could Bring Bigger Checks: IRS Withholding Decision, “Free Money” Buzz, and Key Filing Changes Under the One Big Beautiful Bill Act

The IRS did not update federal income tax withholding tables for 2025, despite new deductions under the One Big Beautiful Bill Act. Many workers may see larger-than-usual refunds when filing 2025 returns in early 2026. Analysts and officials predict record refunds, with estimates ranging from $91 billion to $150 billion in total payouts. Tax experts caution that bigger refunds reflect over-withholding, not “free money.”
26 December 2025
Grupo Aeroméxico (AERO) Stock Today: Latest News, Analyst Targets, Earnings Outlook, and What to Watch Before the NYSE Open

Grupo Aeroméxico (AERO) Stock Today: Latest News, Analyst Targets, Earnings Outlook, and What to Watch Before the NYSE Open

Aeroméxico shares (NYSE: AERO) last closed at $22.18 and indicated higher pre-market at $22.73, following a recent 52-week high of $22.26. The airline returned to public markets on November 6, 2025, with each NYSE ADS representing 10 Mexican shares. Trading remains thin post-holiday, and analysts note increased sensitivity to headlines and regulatory news.
26 December 2025
··
Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

Abivax (NASDAQ: ABVX) rose about 5.3% to $145.31 in premarket trading Friday, with U.S. markets the main venue as Euronext remained closed for St. Stephen’s Day. The stock has surged in December amid Eli Lilly takeover rumors, recent inclusion in the Nasdaq Biotechnology Index, and ongoing interest in its ulcerative colitis drug obefazimod.
26 December 2025
···
POSCO Holdings Stock (NYSE: PKX) in Focus Ahead of the U.S. Open: Louisiana Green-Steel Bet, Lithium Supply Deals, and What Investors Are Watching

POSCO Holdings Stock (NYSE: PKX) in Focus Ahead of the U.S. Open: Louisiana Green-Steel Bet, Lithium Supply Deals, and What Investors Are Watching

POSCO Holdings ADR (NYSE: PKX) traded around $53.50 premarket Friday, down about 2% on light volume ahead of the NYSE open. The move follows POSCO’s disclosure of a $582 million plan to acquire a 20% stake in Hyundai Steel Louisiana LLC, aiming to expand U.S. “green steel” operations. U.S. stock index futures pointed to a flat open amid thin, post-holiday trading.
26 December 2025
·
Zai Lab Limited Stock (NASDAQ: ZLAB) Today: Pre‑Market Watchlist After China’s COBENFY Approval, NRDL Renewals, and Fresh Pipeline Catalysts

Zai Lab Limited Stock (NASDAQ: ZLAB) Today: Pre‑Market Watchlist After China’s COBENFY Approval, NRDL Renewals, and Fresh Pipeline Catalysts

Zai Lab shares were indicated around $18.58 premarket Friday, valuing the company near $2.1 billion. China approved COBENFY for schizophrenia on December 23, adding to recent company catalysts. U.S. markets reopen for a full session after the Christmas holiday, with thin liquidity and wider spreads expected. ZLAB’s 52-week range spans $16.82 to $44.34, with momentum indicators near oversold levels.
26 December 2025
···
Edgewise Therapeutics (EWTX) Stock Surges on EDG-7500 Safety Update as Wall Street Prepares to Reopen After Christmas

Edgewise Therapeutics (EWTX) Stock Surges on EDG-7500 Safety Update as Wall Street Prepares to Reopen After Christmas

Edgewise Therapeutics shares closed at $27.38 on December 24, up 26% after the company reported a favorable interim safety update for its EDG-7500 therapy in hypertrophic cardiomyopathy. Pre-market trading showed the stock at $27.46 as of 8:52 a.m. ET Friday. No clinically meaningful drops in ejection fraction or new atrial fibrillation were seen in the latest trial cohort. Regular U.S. trading resumes at 9:30 a.m. ET.
26 December 2025
···
Oracle Stock Heads for Worst Quarter Since 2001 as AI Spending Fears Collide With OpenAI, TikTok, and Hollywood Bets

Oracle Stock Heads for Worst Quarter Since 2001 as AI Spending Fears Collide With OpenAI, TikTok, and Hollywood Bets

Oracle shares have fallen about 30% this quarter, putting the stock on track for its steepest quarterly drop since 2001. Investors are concerned about the company’s ability to fund large AI data-center projects without straining its finances. Oracle reported fiscal Q2 revenue of $16.1 billion, up 14%, and a cloud backlog of $523 billion, up 438% year over year.
26 December 2025
···
Almonty Industries (ALM) Stock Today: Sangdong Tungsten Milestone, Fresh Funding, Analyst Targets, and What to Watch Before the Open

Almonty Industries (ALM) Stock Today: Sangdong Tungsten Milestone, Fresh Funding, Analyst Targets, and What to Watch Before the Open

Almonty Industries began commercial mining at its Sangdong tungsten mine in South Korea, delivering first ore to the ROM pad on December 16. Shares traded near $9.44 in pre-market Friday, up 6.8%. The company recently completed a U.S. equity raise to fund further tungsten projects. U.S. markets were set for a light post-Christmas session, with Nasdaq opening at 9:30 a.m. ET.
26 December 2025
··
Travere Therapeutics (TVTX) Stock Watch: Pre‑Market Focus on the Jan. 13 FDA Decision After a 14% Rally

Travere Therapeutics (TVTX) Stock Watch: Pre‑Market Focus on the Jan. 13 FDA Decision After a 14% Rally

Travere Therapeutics shares closed at $40.28 on Dec. 24, up 13.9% after bullish analyst commentary and anticipation of an FDA decision on FILSPARI for FSGS by Jan. 13, 2026. Early pre-market trading Friday showed TVTX around $40.6. The FDA dropped plans for an advisory committee meeting, which some investors see as a positive sign. Trading volume remains light due to the holiday.
26 December 2025
American Airlines Will Hold Some Flights for Tight Connections: How the New Connect Assist “Short Hold” Service Works, Where It’s Live, and What Travelers Should Know

American Airlines Will Hold Some Flights for Tight Connections: How the New Connect Assist “Short Hold” Service Works, Where It’s Live, and What Travelers Should Know

American Airlines is using an AI-driven system called Connect Assist to briefly hold certain departing flights for late-arriving connecting passengers, if it won’t disrupt the broader schedule. The tool, tested at Dallas–Fort Worth, analyzes dozens of factors to decide when a short hold is feasible. The program targets tight connections, not all delays. Boarding still closes 15 minutes before departure.
26 December 2025
·
Polestar Stock (PSNY) News Today: Fresh Funding, Reverse Split Fallout, and What Investors Should Watch Before the Dec. 26 Open

Polestar Stock (PSNY) News Today: Fresh Funding, Reverse Split Fallout, and What Investors Should Watch Before the Dec. 26 Open

Polestar Automotive (PSNY) entered Friday’s premarket session indicated near $17.18, with investors watching a $300 million equity raise and a $300 million debt-to-equity conversion backed by Geely. U.S. stock markets had not yet opened at 9:00 a.m. ET after a holiday-shortened week, with trading volumes expected to be thin and index futures near flat.
26 December 2025
·
Applied Digital (APLD) Stock News, Forecasts and Analysis for Dec. 26, 2025: Macquarie Financing, Hyperscaler Deals, and What Comes Next

Applied Digital (APLD) Stock News, Forecasts and Analysis for Dec. 26, 2025: Macquarie Financing, Hyperscaler Deals, and What Comes Next

Applied Digital shares traded at $25.72 on Dec. 26, 2025, with a $7.18 billion market cap after sharp swings tied to new Macquarie-backed financing. The company disclosed a $100 million loan facility for AI data center development, with $45 million funded at closing and an 8% interest rate. SEC filings detailed terms and risks, fueling debate over financing costs and execution.
26 December 2025
·
1 … 367 368 369 370 371 … 584
Go toTop